Lin-Wei Guo

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.

Xin Hu, F. Bertucci, Da-Qiang Li, 2020, Cell metabolism.

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Xin Hu, Keda Yu, G. Di, 2020, Nature Communications.

A Risk Stratification Model for Predicting Survival in Breast Cancer Patients With Lung Metastasis: A Study of the SEER Database and A Chinese Cohort

Xin Hu, Y. Gong, Lin-Wei Guo, 2021 .

Large‐scale genomic sequencing reveals adaptive opportunity of targeting mutated‐PI3Kα in early and advanced HER2‐positive breast cancer

Xin Hu, Z. Shao, Li Chen, 2021, Clinical and translational medicine.

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer

Xin Hu, H. Zhang, Y. Gong, 2018, Cancer management and research.

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer

Xin Hu, Z. Shao, G. Di, 2022, Science advances.

Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer

Hefen Sun, Xin Hu, Y. Gong, 2020, Medical science monitor : international medical journal of experimental and clinical research.

Improving the value of molecular testing: current status and opportunities in colorectal cancer precision medicine

Lin-Wei Guo, Ye Xu, Chenchen Wang, 2023, Cancer biology & medicine.